DCLAK11, a multi-tyrosine kinase inhibitor, exhibits potent antitumor and antiangiogenic activity in vitro

Autor Guo, Xiao-bin, Chen, Xian-jie, Tong, Lin-jiang, Peng, Xia, Huang, Min, Liu, Hong-chun, Liu, Hong, Ding, Jian
Vydáno v Acta Pharmacol Sin (2015)

MFTZ-1 reduces constitutive and inducible HIF-1α accumulation and VEGF secretion independent of its topoisomerase II inhibition

Autor Dai, Mei, Miao, Ze-Hong, Ren, Xuan, Tong, Lin-Jiang, Yang, Na, Li, Ting, Lin, Li-Ping, Shen, Yue-Mao, Ding, Jian
Vydáno 2010

GA3, a new gambogic acid derivative, exhibits potent antitumor activities in vitro via apoptosis-involved mechanisms

Autor Xie, Hua, Qin, Yu-xin, Zhou, Yun-long, Tong, Lin-jiang, Lin, Li-ping, Geng, Mei-yu, Duan, Wen-hu, Ding, Jian
Vydáno 2009

Characterization of the conversion between CD133(+) and CD133(-) cells in colon cancer SW620 cell line

Autor Feng, Jian-Ming, Miao, Ze-Hong, Jiang, Yi, Chen, Yi, Li, Jia-Xin, Tong, Lin-Jiang, Zhang, Jin, Huang, Yi-Ran, Ding, Jian
Vydáno 2012

Discovery and biological evaluation of N-(3-(7-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-4-methyl-2-oxo-2H-pyrimido[4,5-d][1,3]oxazin-1(4H)-yl)phenyl)acrylamide as potent...

Autor Lai, Meng-zhen, Song, Pei-ran, Dou, Dou, Diao, Yan-yan, Tong, Lin-jiang, Zhang, Tao, Xie, Hua, Li, Hong-lin, Ding, Jian
Vydáno v Acta Pharmacol Sin (2019)

Anti-proliferative effects, cell cycle G(2)/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines

Autor Lu, Da Yong, Huang, Min, Xu, Cheng Hui, Yang, Wei Yi, Hu, Chao Xin, Lin, Li Ping, Tong, Lin Jiang, Li, Mei Hong, Lu, Wei, Zhang, Xiong Wen, Ding, Jian
Vydáno 2005

Naphthalimides Induce G(2) Arrest Through the ATM-Activated Chk2-Executed Pathway in HCT116 Cells

Autor Zhu, Hong, Miao, Ze-Hong, Huang, Min, Feng, Jian-Ming, Zhang, Zhi-Xiang, Lu, Jin-Jian, Cai, Yu-Jun, Tong, Lin-Jiang, Xu, Yu-Fang, Qian, Xu-Hong, Ding, Jian
Vydáno 2009

Increased accumulation of hypoxia-inducible factor-1α with reduced transcriptional activity mediates the antitumor effect of triptolide

Autor Zhou, Zhao-Li, Luo, Zhi-Guo, Yu, Bing, Jiang, Yi, Chen, Yi, Feng, Jian-Ming, Dai, Mei, Tong, Lin-Jiang, Li, Zheng, Li, Yuan-Chao, Ding, Jian, Miao, Ze-Hong
Vydáno 2010

Drug Transporter-independent Liver Cancer Cell Killing by a Marine Steroid Methyl Spongoate via Apoptosis Induction

Autor Jiang, Yi, Miao, Ze-Hong, Xu, Lei, Yu, Bing, Gong, Jing-Xu, Tong, Lin-Jiang, Chen, Yi, Zhou, Zhao-Li, Liu, Hong-Chun, Wang, Yi, Guo, Yue-Wei, Ding, Jian
Vydáno 2011

Establishment of platform for screening insulin-like growth factor-1 receptor inhibitors and evaluation of novel inhibitors

Autor Tong, Lin-jiang, Xie, Hua, Peng, Ting, Liu, Xiao-feng, Xin, Xian-liang, Huang, Xun, Chen, Si-meng, Liu, Hong-yan, Li, Hong-lin, Geng, Mei-yu, Yin, Ming, Ding, Jian
Vydáno 2011

Identification of DW532 as a novel anti-tumor agent targeting both kinases and tubulin

Autor Peng, Ting, Wu, Jian-rui, Tong, Lin-jiang, Li, Meng-yuan, Chen, Fang, Leng, Yi-xin, Qu, Rong, Han, Kun, Su, Yi, Chen, Yi, Duan, Wen-hu, Xie, Hua, Ding, Jian
Vydáno 2014

DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo

Autor Li, Meng-yuan, Lv, Yong-cong, Tong, Lin-jiang, Peng, Ting, Qu, Rong, Zhang, Tao, Sun, Yi-ming, Chen, Yi, Wei, Li-xin, Geng, Mei-yu, Duan, Wen-hu, Xie, Hua, Ding, Jian
Vydáno v Acta Pharmacol Sin (2016)

C11, a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor, suppresses breast cancer metastasis and angiogenesis

Autor Chen, Zhuo, Tong, Lin-jiang, Tang, Bai-you, Liu, Hong-yan, Wang, Xin, Zhang, Tao, Cao, Xian-wen, Chen, Yi, Li, Hong-lin, Qian, Xu-hong, Xu, Yu-fang, Xie, Hua, Ding, Jian
Vydáno v Acta Pharmacol Sin (2018)

Identification of compound D2923 as a novel anti-tumor agent targeting CSF1R

Autor Liu, Ying-Qiang, Wang, Ya-Nan, Lu, Xiao-Yun, Tong, Lin-Jiang, Li, Yan, Zhang, Tao, Xun, Qiu-Ju, Feng, Fang, Chen, Yu-Zhe, Su, Yi, Shen, Yan-Yan, Chen, Yi, Geng, Mei-Yu, Ding, Ke, Li, Yan-Li, Xie, Hua, Ding, Jian
Vydáno v Acta Pharmacol Sin (2018)

Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution

Autor He, Jin-Xue, Wang, Meng, Huan, Xia-Juan, Chen, Chuan-Huizi, Song, Shan-Shan, Wang, Ying-Qing, Liao, Xue-Mei, Tan, Cun, He, Qian, Tong, Lin-Jiang, Wang, Yu-Ting, Li, Xiao-Hua, Su, Yi, Shen, Yan-Yan, Sun, Yi-Ming, Yang, Xin-Ying, Chen, Yi, Gao, Zhi-Wei, Chen, Xiao-Yan, Xiong, Bing, Lu, Xiu-Lian, Ding, Jian, Yang, Chun-Hao, Miao, Ze-Hong
Vydáno v Oncotarget (2016)